The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals

PLoS Pathog. 2020 Feb 20;16(2):e1008258. doi: 10.1371/journal.ppat.1008258. eCollection 2020 Feb.

Abstract

The absence of the Duffy protein at the surface of erythrocytes was considered for decades to confer full protection against Plasmodium vivax as this blood group is the receptor for the key parasite ligand P. vivax Duffy binding protein (PvDBP). However, it is now clear that the parasite is able to break through this protection and induce clinical malaria in Duffy-negative people, although the underlying mechanisms are still not understood. Here, we briefly review the evidence of Duffy-negative infections by P. vivax and summarize the current hypothesis at the basis of this invasion process. We discuss those in the perspective of malaria-elimination challenges, notably in African countries.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Africa
  • Antigens, Protozoan / metabolism*
  • Duffy Blood-Group System / metabolism*
  • Humans
  • Malaria, Vivax / metabolism*
  • Malaria, Vivax / prevention & control
  • Plasmodium vivax* / metabolism
  • Plasmodium vivax* / pathogenicity
  • Protozoan Proteins / metabolism*
  • Receptors, Cell Surface / metabolism*

Substances

  • Antigens, Protozoan
  • Duffy Blood-Group System
  • Duffy antigen binding protein, Plasmodium
  • Protozoan Proteins
  • Receptors, Cell Surface

Grants and funding

Agence Nationale de la Recherche Tremplin-ERC (TERC3) 2017 http://www.agence- nationale-recherche.fr/Project-ANR-17-ERC3-0002 (grant number EVAD: Evolutionary history and genetic adaptation of Plasmodium vivax). Received by VR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.